Nuvectis Pharma to participate in upcoming investor conferences
Nuvectis Pharma said it will participate in upcoming investor conferences. The clinical-stage biopharmaceutical company focuses on complement-related conditions and oncology.
Fort Lee, NJ, Sept.
03, 2026 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc.
NASDAQ:NVCT ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of innovative therapies for the treatment of complement-related conditions and oncology, today announced that membe…